Help Therapeutics Completes Series C Financing of 25 Million Dollars

Help Therapeutics Completes Series C Financing of 25 Million Dollars

Post Views: 93 Help Therapeutics As the first company in China to develop and manufacture cell therapy using induced pluripotent stem cell (iPSC) technology, Help Therapeutics insists on focusing on the fields of heart failure and tumor immune diseases to develop general-purpose cell therapy products to meet clinical demand. The company’s founder, Dr. Wang Jiaxian,…